Sabrina Mogle BS

Sabrina received her first exposure in orphan drug regulations while working for the ex-Director of the Office of Orphan Products, discovering her passion for the rare disease space. She has led and coordinated business and corporate development strategies at rare disease consulting firms and held Business Development and Director-level roles for global preclinical Contract Research Organizations. She has successfully channeled a passion for both business and science into building RareMoon, an global orphan drug regulatory services firm focused on translating science into concise regulatory documents in preparation for key clinical trials.